Dr. Susin has published more than 135 manuscripts on mitochondria, PCD and its mechanisms. Overall, these papers have given rise to more than 25,500 citations (~900 citations/year; Average Citations per Item: 190) and an h-index: 70 (Web of Science, July 2017). Co-inventor of 5 patent applications with international extension, Dr. Susin has been one of the protagonists of two scientific hits in his field: (a) He has shown that mitochondria do not only have a vital, bioenergetic and metabolic function but they also control PCD and (b) He has discovered AIF (Apoptosis-Inducing factor), a protein defining the caspase-independent mode of PCD. A translational PCD analysis has extended Dr Susin’s research into a general assessment of the causes of apoptotic drug resistance in CLL. Dr. Susin has coordinated projects for the ANR, INCa, ARC, FRM, Fondation de France, Association L. Fugain, and Ligue Cancer and he also serves as a reviewer in more than 30 scientific journals.